Pay in 4 interest-free payments of $5.46 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
GLP-1 agonists, not the only drugs to address more than one indication This is not the first time that a drug has been used for several indications
The first incretin-based drug approved specifically for weight loss was liraglutide (Saxenda), developed by Novo Nordisk
Physician-supervised programs help patients understand these normal changes and adjust their plan when necessary instead of becoming discouraged
Management includes eating smaller meals, avoiding high-fat foods, staying hydrated, and gradual dose titration as recommended in UK prescribing guidance
Avoid high-dose pills of Ginkgo biloba, garlic, and Vitamin E unless specifically cleared by your hematologist
:max_bytes(150000):strip_icc():focal(748x241:750x243)/Serena-Williams-1-012726-2698f17c5ab647929a79194c436d85ea.jpg)
